CYTOKINETICS INC
CYTK
65 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | May 5 8:20 PM | Wendell WierengaDirector | Sale | 4,032 | $75.00 | $302.4K | 32,637(D) | View → |
| May 5, 2026 | May 5 8:18 PM | Sung LeeEVP, Chief Financial Officer | Sale | 23,906 | $76.87 | $1.8M | 63,221(D) | View → |
| May 5, 2026 | May 5 8:15 PM | John T HendersonDirector | Sale | 20,000 | $75.97 | $1.5M | 75,237(D) | View → |
| May 5, 2026 | May 5 8:11 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 11,333 | $77.25 | $875.5K | 58,555(D) | View → |
| May 1, 2026 | May 4 8:01 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,857 | $65.00 | $1.0M | 58,555(D) | View → |
| Apr 30, 2026 | Apr 30 8:22 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,000 | $63.26 | $948.9K | 58,555(D) | View → |
| Apr 29, 2026 | Apr 29 8:23 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $59.62 | $447.1K | 407,830(D) | View → |
| Apr 21, 2026 | Apr 21 8:22 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $65.69 | $229.9K | 153,902(D) | View → |
| Apr 15, 2026 | Apr 15 9:29 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 7,449 | $66.02 | $491.8K | 58,555(D) | View → |
| Apr 15, 2026 | Apr 15 9:27 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $65.38 | $490.3K | 415,330(D) | View → |
| Apr 15, 2026 | Apr 15 8:55 PM | ANDREW CALLOS | Proposed Sale | 79,639 | $66.35 | $5.3M | — | View → |
| Apr 7, 2026 | Apr 8 8:18 PM | Fady Ibraham MalikEVP Research & Development | Sale | 4,500 | $65.11 | $293.0K | 153,902(D) | View → |
| Apr 7, 2026 | Apr 7 8:26 PM | FADY MALIK | Proposed Sale | 22,000 | $64.94 | $1.4M | — | View → |
| Apr 1, 2026 | Apr 1 8:47 PM | ROBERT BLUM | Proposed Sale | 45,000 | $65.91 | $3.0M | — | View → |
| Apr 1, 2026 | Apr 1 8:34 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $66.63 | $499.7K | 422,830(D) | View → |
| Mar 31, 2026 | Mar 31 8:24 PM | ANDREW CALLOS | Proposed Sale | 3,639 | $62.97 | $229.1K | — | View → |
| Mar 31, 2026 | Mar 31 8:21 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 3,639 | $65.00 | $236.5K | 66,004(D) | View → |
| Mar 17, 2026 | Mar 18 9:46 PM | Sung LeeEVP, Chief Financial Officer | Sale | 4,935 | $62.15 | $306.7K | 87,127(D) | View → |
| Mar 17, 2026 | Mar 18 9:43 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 8,542 | $62.15 | $530.9K | 71,573(D) | View → |
| Mar 17, 2026 | Mar 18 9:40 PM | Fady Ibraham MalikEVP Research & Development | Sale | 12,033 | $62.15 | $747.9K | 153,902(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Jun 29 10:05 PM | Sung LeeEVP, Chief Financial Officer | Option Exercise | 38,730 | $48.51 | 27,821(D) | View → |
| Jun 29, 2026 | Jun 29 9:23 PM | Sung LeeEVP, Chief Financial Officer | Option Exercise | 3,134 | $48.51 | 39,681(D) | View → |
| Jun 23, 2026 | Jun 23 9:41 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 40,886(D) | View → |
| Jun 9, 2026 | Jun 9 9:40 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 44,386(D) | View → |
| Jun 1, 2026 | Jun 1 10:51 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 39,000(D) | View → |
| May 27, 2026 | May 27 11:16 PM | Muna BhanjiDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:14 PM | James M DalyDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:13 PM | Robert Arthur HarringtonDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:12 PM | John T HendersonDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:11 PM | Edward M. Kaye MDDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:10 PM | Lynne B ParshallDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:09 PM | Robert E LandryDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:08 PM | Wendell WierengaDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:07 PM | Nancy WysenskiDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 19, 2026 | May 20 8:00 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 47,886(D) | View → |
| May 5, 2026 | May 5 9:35 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 51,386(D) | View → |
| May 5, 2026 | May 5 8:20 PM | Wendell WierengaDirector | Option Exercise | 4,032 | $12.40 | 0(D) | View → |
| May 5, 2026 | May 5 8:15 PM | John T HendersonDirector | Option Exercise | 20,000 | $7.61 | 0(D) | View → |
| May 5, 2026 | May 5 8:11 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 11,333 | $39.13 | 13,070(D) | View → |
| May 1, 2026 | May 4 8:01 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,857 | $37.63 | 0(D) | View → |
Page 1 of 2
Next →